ReP USP - Resultado da busca

Artigo de periodico
Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts (2023)
Vicentini, Anna Beatriz; Rodrigues, Lucas Silva; Rossi, Giordano Novak ; Rocha, Juliana Mendes; Guerra, Lorena Terene Lopes; Reis, José Augusto Silva; Maekawa, Renan Massanobu; Osório, Flávia de Lima; Bouso, José Carlos; Santos, Fabiana Pereira; Paranhos, Beatriz Aparecida Passos Bismara ; Yonamine, Maurício ; Hallak, Jaime Eduardo Cecílio; Santos, Rafael Guimarães dos
Source: Psychoactives. Unidades: EERP, FMRP, FCF
Subjects: ALUCINOGÊNICOS, ESTUDANTES UNIVERSITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICENTINI, Anna Beatriz et al. Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts. Psychoactives, v. 2, p. 346–358, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/psychoactives2040022. Acesso em: 03 nov. 2024.
APA
Vicentini, A. B., Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Guerra, L. T. L., Reis, J. A. S., et al. (2023). Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts. Psychoactives, 2, 346–358. doi:10.3390/psychoactives2040022
NLM
Vicentini AB, Rodrigues LS, Rossi GN, Rocha JM, Guerra LTL, Reis JAS, Maekawa RM, Osório F de L, Bouso JC, Santos FP, Paranhos BAPB, Yonamine M, Hallak JEC, Santos RG dos. Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts [Internet]. Psychoactives. 2023 ; 2 346–358.[citado 2024 nov. 03 ] Available from: https://dx.doi.org/10.3390/psychoactives2040022
Vancouver
Vicentini AB, Rodrigues LS, Rossi GN, Rocha JM, Guerra LTL, Reis JAS, Maekawa RM, Osório F de L, Bouso JC, Santos FP, Paranhos BAPB, Yonamine M, Hallak JEC, Santos RG dos. Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts [Internet]. Psychoactives. 2023 ; 2 346–358.[citado 2024 nov. 03 ] Available from: https://dx.doi.org/10.3390/psychoactives2040022
Artigo de periodico
Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia (2018)
Peres, Fernanda Fiel; Diana, Mariana C.; Levin, Raquel; Suiama, Mayra Akimi; Almeida, Valéria; Vendramini, Ana M.; Santos, Camila M.; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa Costhek
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ESQUIZOFRENIA, SEROTONINA, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda Fiel et al. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00901. Acesso em: 03 nov. 2024.
APA
Peres, F. F., Diana, M. C., Levin, R., Suiama, M. A., Almeida, V., Vendramini, A. M., et al. (2018). Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00901
NLM
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00901
Vancouver
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00901
Artigo de periodico
Cannabidiol as a promising strategy to treat and prevent movement disorders? (2018)
Peres, Fernanda Fiel; Lima, Alvaro da Costa; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Silva, Regina H.; Abilio, Vanessa Costhek
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: DOENÇA DE PARKINSON, CANABINOIDES, DISCINESIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda Fiel et al. Cannabidiol as a promising strategy to treat and prevent movement disorders?. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00482. Acesso em: 03 nov. 2024.
APA
Peres, F. F., Lima, A. da C., Hallak, J. E. C., Crippa, J. A. de S., Silva, R. H., & Abilio, V. C. (2018). Cannabidiol as a promising strategy to treat and prevent movement disorders? Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00482
NLM
Peres FF, Lima A da C, Hallak JEC, Crippa JA de S, Silva RH, Abilio VC. Cannabidiol as a promising strategy to treat and prevent movement disorders? [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00482
Vancouver
Peres FF, Lima A da C, Hallak JEC, Crippa JA de S, Silva RH, Abilio VC. Cannabidiol as a promising strategy to treat and prevent movement disorders? [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00482
Artigo de periodico
No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study (2018)
Linares, Ila Marques Porto; Guimarães, Francisco Silveira; Eckeli, Alan Luiz; Crippa, Ana C. S.; Zuardi, Antônio Waldo; Souza, José Dalmo Silva de; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, POLISSONOGRAFIA, NEUROPSIQUIATRIA, CICLO VIGÍLIA-SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINARES, Ila Marques Porto et al. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00315. Acesso em: 03 nov. 2024.
APA
Linares, I. M. P., Guimarães, F. S., Eckeli, A. L., Crippa, A. C. S., Zuardi, A. W., Souza, J. D. S. de, et al. (2018). No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study. Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00315
NLM
Linares IMP, Guimarães FS, Eckeli AL, Crippa ACS, Zuardi AW, Souza JDS de, Hallak JEC, Crippa JA de S. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00315
Vancouver
Linares IMP, Guimarães FS, Eckeli AL, Crippa ACS, Zuardi AW, Souza JDS de, Hallak JEC, Crippa JA de S. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00315
Artigo de periodico
Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research (2017)
Ruggiero, Rafael N.; Rossignoli, Matheus T.; De Ross, Jana B.; Hallak, Jaime Eduardo Cecílio
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ANSIOLÍTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUGGIERO, Rafael N. et al. Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00399. Acesso em: 03 nov. 2024.
APA
Ruggiero, R. N., Rossignoli, M. T., De Ross, J. B., & Hallak, J. E. C. (2017). Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00399
NLM
Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC. Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00399
Vancouver
Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC. Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00399
Artigo de periodico
Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life (2017)
Zuardi, Antonio Waldo; Rodrigues, Natália P.; Silva, Angélica L.; Bernardo, Sandra A.; Hallak, Jaime Eduardo Cecílio; Guimarães, Francisco Silveira; Crippa, José Alexandre de Souza
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ANSIOLÍTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUARDI, Antonio Waldo et al. Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00259. Acesso em: 03 nov. 2024.
APA
Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. de S. (2017). Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00259
NLM
Zuardi AW, Rodrigues NP, Silva AL, Bernardo SA, Hallak JEC, Guimarães FS, Crippa JA de S. Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00259
Vancouver
Zuardi AW, Rodrigues NP, Silva AL, Bernardo SA, Hallak JEC, Guimarães FS, Crippa JA de S. Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00259
Artigo de periodico
Protective effects of Cannabidiol against seizures and neuronal death in a rat model of mesial temporal lobe epilepsy (2017)
Val-da-Silva, Raquel A. do; Peixoto-Santos, Jose E.; Kandratavicius, Ludmyla; De Ross, Jana B.; Esteves, Ingrid; De Martinis, Bruno S.; Alves, Marcela N. R.; Scandiuzzi, Renata Caldo; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Leite, João Pereira
Source: Frontiers in Pharmacology. Unidades: FFCLRP, FMRP
Subjects: MODELOS ANIMAIS, CANABINOIDES, EPILEPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAL-DA-SILVA, Raquel A. do et al. Protective effects of Cannabidiol against seizures and neuronal death in a rat model of mesial temporal lobe epilepsy. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00131. Acesso em: 03 nov. 2024.
APA
Val-da-Silva, R. A. do, Peixoto-Santos, J. E., Kandratavicius, L., De Ross, J. B., Esteves, I., De Martinis, B. S., et al. (2017). Protective effects of Cannabidiol against seizures and neuronal death in a rat model of mesial temporal lobe epilepsy. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00131
NLM
Val-da-Silva RA do, Peixoto-Santos JE, Kandratavicius L, De Ross JB, Esteves I, De Martinis BS, Alves MNR, Scandiuzzi RC, Hallak JEC, Zuardi AW, Crippa JA de S, Leite JP. Protective effects of Cannabidiol against seizures and neuronal death in a rat model of mesial temporal lobe epilepsy [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00131
Vancouver
Val-da-Silva RA do, Peixoto-Santos JE, Kandratavicius L, De Ross JB, Esteves I, De Martinis BS, Alves MNR, Scandiuzzi RC, Hallak JEC, Zuardi AW, Crippa JA de S, Leite JP. Protective effects of Cannabidiol against seizures and neuronal death in a rat model of mesial temporal lobe epilepsy [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00131
Artigo de periodico
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats (2016)
Peres, Fernanda F.; Levin, Raquel; Suiama, Mayra A.; Diana, Mariana C.; Gouvêa, Douglas A.; Almeida, Valéria; Santos, Camila M.; Lungato, Lisandro; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; D’Almeida, Vânia; Silva, Regina H.; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00343. Acesso em: 03 nov. 2024.
APA
Peres, F. F., Levin, R., Suiama, M. A., Diana, M. C., Gouvêa, D. A., Almeida, V., et al. (2016). Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00343
NLM
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Vancouver
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Artigo de periodico
Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol (2016)
Crippa, José Alexandre de Souza; Crippa, Ana C. S.; Hallak, Jaime Eduardo Cecílio; Martín-Santos, Rocio; Zuardi, Antônio Waldo
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, EPILEPSIA, ELETROFISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00359. Acesso em: 03 nov. 2024.
APA
Crippa, J. A. de S., Crippa, A. C. S., Hallak, J. E. C., Martín-Santos, R., & Zuardi, A. W. (2016). Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00359
NLM
Crippa JA de S, Crippa ACS, Hallak JEC, Martín-Santos R, Zuardi AW. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2016.00359
Vancouver
Crippa JA de S, Crippa ACS, Hallak JEC, Martín-Santos R, Zuardi AW. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2016.00359
Artigo de periodico
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy (2016)
Peres, Fernanda F.; Levin, Raquel; Almeida, Valéria; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, MODELOS ANIMAIS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 03 nov. 2024.
APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303
NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Artigo de periodico
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (2014)
Levin, Raquel; Peres, Fernanda F.; Almeida, Valéria; Calzavara, Mariana B.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ESQUIZOFRENIA, TERAPÊUTICA MÉDICA, CANNABIS, SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVIN, Raquel et al. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Frontiers in Pharmacology, v. 5, 2014Tradução . . Disponível em: https://doi.org/10.3389/fphar.2014.00010. Acesso em: 03 nov. 2024.
APA
Levin, R., Peres, F. F., Almeida, V., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., et al. (2014). Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Frontiers in Pharmacology, 5. doi:10.3389/fphar.2014.00010
NLM
Levin R, Peres FF, Almeida V, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain [Internet]. Frontiers in Pharmacology. 2014 ; 5[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2014.00010
Vancouver
Levin R, Peres FF, Almeida V, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain [Internet]. Frontiers in Pharmacology. 2014 ; 5[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2014.00010
Artigo de periodico
Marijuana, feijoada and the debate on drug legalization (2013)
Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: CANNABIS (TERAPIA;EFEITOS), PSIQUIATRIA (EFEITOS), FÁRMACOS DE ORIGEM VEGETAL (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza e HALLAK, Jaime Eduardo Cecílio e ZUARDI, Antonio Waldo. Marijuana, feijoada and the debate on drug legalization. Frontiers in Psychiatry, v. 4, n. 7, p. 1-2, 2013Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2013.00007. Acesso em: 03 nov. 2024.
APA
Crippa, J. A. de S., Hallak, J. E. C., & Zuardi, A. W. (2013). Marijuana, feijoada and the debate on drug legalization. Frontiers in Psychiatry, 4( 7), 1-2. doi:10.3389/fpsyt.2013.00007
NLM
Crippa JA de S, Hallak JEC, Zuardi AW. Marijuana, feijoada and the debate on drug legalization [Internet]. Frontiers in Psychiatry. 2013 ; 4( 7): 1-2.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fpsyt.2013.00007
Vancouver
Crippa JA de S, Hallak JEC, Zuardi AW. Marijuana, feijoada and the debate on drug legalization [Internet]. Frontiers in Psychiatry. 2013 ; 4( 7): 1-2.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fpsyt.2013.00007
Trabalho de evento-resumo periodico
Cannabidiol has long-term anti-inflammatory effects in a murine model of acute lung injury: role for the A2A adenosine receptor (2011)
Ribeiro, Alison; Ferraz de Paula, Viviane; Pinheiro, Milena Lobão; Quinteiro Filho, Wanderley Moreno; Akamine, Adriana Tiemi; Almeida, V. I; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Palermo-Neto, João
Source: Neuroimmunomodulation. Conference titles: Congress of the International Society for Neuroimmunomodulation. Unidades: FMRP, FMVZ
Subjects: FÁRMACOS IMUNOSSUPRESSORES, INFLAMAÇÃO, FARMACOLOGIA VETERINÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Alison et al. Cannabidiol has long-term anti-inflammatory effects in a murine model of acute lung injury: role for the A2A adenosine receptor. Neuroimmunomodulation. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1159/000331256. Acesso em: 03 nov. 2024. , 2011
APA
Ribeiro, A., Ferraz de Paula, V., Pinheiro, M. L., Quinteiro Filho, W. M., Akamine, A. T., Almeida, V. I., et al. (2011). Cannabidiol has long-term anti-inflammatory effects in a murine model of acute lung injury: role for the A2A adenosine receptor. Neuroimmunomodulation. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1159/000331256
NLM
Ribeiro A, Ferraz de Paula V, Pinheiro ML, Quinteiro Filho WM, Akamine AT, Almeida VI, Hallak JEC, Zuardi AW, Crippa JA de S, Palermo-Neto J. Cannabidiol has long-term anti-inflammatory effects in a murine model of acute lung injury: role for the A2A adenosine receptor [Internet]. Neuroimmunomodulation. 2011 ; 18( 6): 400-401.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1159/000331256
Vancouver
Ribeiro A, Ferraz de Paula V, Pinheiro ML, Quinteiro Filho WM, Akamine AT, Almeida VI, Hallak JEC, Zuardi AW, Crippa JA de S, Palermo-Neto J. Cannabidiol has long-term anti-inflammatory effects in a murine model of acute lung injury: role for the A2A adenosine receptor [Internet]. Neuroimmunomodulation. 2011 ; 18( 6): 400-401.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1159/000331256

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation